We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Targets Alzheimer's Products In Supplement Crackdown

Law360 (February 11, 2019, 8:58 PM EST) -- The U.S. Food and Drug Administration said Monday that it sent warning and advisory letters to 17 companies selling products purporting to treat Alzheimer's disease and other illnesses without FDA approval....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.